ProCE Banner Activity

Expert Audio From France and the UK on Strategies to Reduce HCV Incidence in Key Populations

Audio Download
This on-demand audio features expert perspectives on HCV elimination efforts in France and the UK and highlights globally applicable lessons on treatment as prevention.

Released: May 08, 2019

Expiration: May 06, 2020

No longer available for credit.
Begin Activity

Share

Faculty

Graham R. Foster

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Karine Lacombe

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Gilead

Partners

INHSU

ProCE Banner

Program Director Disclosure

Program Director

Graham R. Foster, FRCP, PhD

Professor of Hepatology
The Liver Unit
Consultant Hepatologist
Queen Mary University of London
London, United Kingdom

Graham R. Foster, FRCP, PhD, has disclosed that he has received consulting fees from AbbVie, Gilead Sciences, GlaxoSmithKline, Merck, and Roche and has ownership interest in GlaxoSmithKline.

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor of Medicine
Infectious Diseases Department
Sorbonne Uiversité
Inserm Pierre Louis School of Public Health
Paris, France

Karine Lacombe, MD, PhD, has disclosed that she has received consulting fees from AbbVie, Gilead Sciences, and Janssen.